Oncolix Inc. (AEPP) wants to help women live longer. 

To help accomplish that mission, the biotech firm is developing novel drugs aimed at eradicating women's cancers such as ovarian and breast cancer.

From the sidelines of the LD Micro conference in Los Angeles, Oncolix CEO Michael Redman tells TheStreet about his company's approach to developing effective treatments using revolutionary scientific research.

 

For more from the LD Micro Conference in La:

TheStreet at LD Micro: What CEO Dave Callaway Sees in Small Caps This Year

STK Owner The ONE Group Is Carving Its Own Unique Space in the Dining Experience

SRAX Chief Weighs in as Company Readies for Cryptocurrency Dividend

Snap Interactive's New Blockchain App Could Flip Video Chat on Its Head

Micro Caps Take the Spotlight at LD Micro Conference - Here's What to Expect

Lexaria Biosciences Is Ready for the Legal Cannabis Boom

Here's How Small Cap Scissor Company Acme United Is Benefitting From Amazon

Here's How Cloud Computing Firm Fusion Is Using M&A to Get Ahead

Amazing Energy Isn't Afraid to Take on Big Oil

More from Video

Norwegian CFO Mark Kempa's Key Insights on Cruising in 2019

Norwegian CFO Mark Kempa's Key Insights on Cruising in 2019

CES 2019: The Future Is Here and it's a Walking Car

CES 2019: The Future Is Here and it's a Walking Car

Takeda Pharmaceutical CEO Talks Big Pharma Trends

Takeda Pharmaceutical CEO Talks Big Pharma Trends

The Story Behind One of America's Biggest Banks - Wells Fargo

The Story Behind One of America's Biggest Banks - Wells Fargo

Financing History: How Citigroup Grew Into a Banking Powerhouse

Financing History: How Citigroup Grew Into a Banking Powerhouse